1 – 20 of 53
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis
(
- Contribution to journal › Article
- 2023
-
Mark
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease : A Retrospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Food Processing and Risk of Crohn's Disease and Ulcerative Colitis : A European Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
- 2022
-
Mark
Obesity is Associated With Increased Risk of Crohn's disease, but not Ulcerative Colitis : A Pooled Analysis of Five Prospective Cohort Studies
(
- Contribution to journal › Article
-
Mark
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases : A Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Association Between Inflammatory Bowel Disease and Spondyloarthritis : Findings from a Nationwide Study in Sweden
(
- Contribution to journal › Article
-
Mark
Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population : a nationwide register-based cohort study 2002–2017
(
- Contribution to journal › Article
-
Mark
Predictors of drug survival : A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
- 2020
-
Mark
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis : results from a nationwide study in Sweden
(
- Contribution to journal › Article
-
Mark
The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
(
- Contribution to journal › Article
- 2019
-
Mark
Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment
(
- Contribution to journal › Article
-
Mark
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Clinical effectiveness of golimumab in Crohn’s disease : an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
-
Mark
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease registries for collection of patient iron parameters in Europe
(
- Contribution to journal › Scientific review
-
Mark
Fibre intake and the development of inflammatory bowel disease : A European prospective multi-centre cohort study (EPIC-IBD)
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
(
- Contribution to journal › Article